Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Two-Year Safety and Efficacy Outcomes with Fostamatinib in Adult Patients with Immune Thrombocytopenia (ITP): Open-Label Extension to Phase 3 Trial Program

Anne-Marie Duliege, MDMS, Donald M. Arnold, MD MSc, FRCPC, Ralph Boccia, MD, Michael Boxer, MD, Nichola Cooper, MRCP, Quentin A Hill, BSc, MBChB, MRCP, FRCPath, Darla K Liles, MD, Michelle Sholzberg, MDM, MSc, FRCPC, Hany Zayed, PhD, Sandra Tong, MD, James B. Bussel, MD

Blood (2018) 132 (Supplement 1): 736.

https://doi.org/10.1182/blood-2018-99-110482

Published: 2018

Journal Articles

Autoimmune Cytopenias Following Alemtuzumab-Induced Renal Transplant: Clinical Features and Treatment Outcomes

Elisa Lucchini, MD, Asad Luqmani, MD, Maria Atta, MD, Simona Deplano, MD PhD, Mark Layton, MB, FRCP, Camelia Vladescu, Deena Paul, Andreas Kousios, MD, Rawya Charif, MD, Nichola Cooper, MRCP

Blood (2018) 132 (Supplement 1): 2434.

https://doi.org/10.1182/blood-2018-99-115258

Published: 2018

Journal Articles

Real World Use of Thrombopoietin-Receptor Agonists in the Management of Immune Thrombocytopenia in the United Kingdom: Results from the TRAIT Study

Nichola Cooper, MRCP, Andrew Provan, Marie Scully, MD MRCP, FRCPath, Henri Grech, Catherine Bagot, MD FRCPath, MBBS, Quentin A Hill, BSc, MBChB, MRCP, FRCPath, Tim Nokes, Nicholas Ramscar, Luke Saunders

Blood (2018) 132 (Supplement 1): 2426.

https://doi.org/10.1182/blood-2018-99-110126

Published: 2018

Journal Articles

Active Immune Thrombocytopenia (ITP) Disease Is Characterised By a Reduced Treg:CD8 Effector T Cell Ratio Which Is Modulated By Thrombopoietin-Receptor Agonists (TPO-RA)

Anwar A. Sayed, MBBS, MSc, Amna Malik, PhD, Ahmad Khoder, MD PhD MRCP, George Adams, MBChB, Nichola Cooper, MRCP

Blood (2018) 132 (Supplement 1): 2430.

https://doi.org/10.1182/blood-2018-99-113563

Published: 2018

Journal Articles

Safety and Efficacy of Romiplostim in over 200 Children with Immune Thrombocytopenia (ITP): Results of an Integrated Database of 5 Clinical Trials

Michael D. Tarantino, MD, Jenny M. Despotovic, DO, MS, John Roy, John Grainger, MD MRCP, FRPATH, Nichola Cooper, MRCP, Donald Beam, Ashok Raj, Alexey A. Maschan, MD, June Kim, PhD, Melissa Jeanne Eisen, MD

Blood (2018) 132 (Supplement 1): 2428.

https://doi.org/10.1182/blood-2018-99-109763

Published: 2018

Journal Articles

Bayesian Analysis of TPO Levels in Immune Thrombocytopenia

George Adams, MBChB, Adam Gosztolai, PhD, Elisa Lucchini, MD, Anwar A. Sayed, MBBS, MSc, Amna Malik, PhD, Nichola Cooper, MRCP

Blood (2018) 132 (Supplement 1): 1157.

https://doi.org/10.1182/blood-2018-99-113454

Published: 2018

Journal Articles

Results from the ITP World IMPACT Survey (I-WISh): Patients with Immune Thrombocytopenia (ITP) Experience Impaired Quality of Life (QoL) Regarding Daily Activities, Social Interactions, Emotional Well-Being and Working Lives

Nichola Cooper, MRCP, Alexandra Kruse, Caroline Kruse, Shirley Watson, Mervyn Morgan, James B. Bussel, MD, Waleed Ghanima, Donald M. Arnold, MD MSc, FRCPC, Cristina Santoro, Ming Hou, MD, Yoshiaki Tomiyama, MD, Serge Laborde, Barbara Lovrencic, John Waller, PhD BSc, Tom Bailey, Gavin Taylor-Stokes, Miona Stankovic, Andrew Provan

Blood (2018) 132 (Supplement 1): 4804.

https://doi.org/10.1182/blood-2018-99-112858

Published: 2018

Journal Articles

Patients with Immune Thrombocytopenia (ITP) Frequently Experience Severe Fatigue but Is It Under-Recognized By Physicians: Results from the ITP World Impact Survey (I-WISh)

Caroline Kruse, Alexandra Kruse, Shirley Watson, Mervyn Morgan, Nichola Cooper, MRCP, Waleed Ghanima, Andrew Provan, Donald M. Arnold, MD MSc, FRCPC, Cristina Santoro, Ming Hou, MD, Yoshiaki Tomiyama, MD, Serge Laborde, Barbara Lovrencic, John Waller, PhD BSc, Gavin Taylor-Stokes, Tom Bailey, Miona Stankovic, James B. Bussel, MD

Blood (2018) 132 (Supplement 1): 2273.

https://doi.org/10.1182/blood-2018-99-112378

Published: 2018

Journal Articles

Rate of Cataracts Across the Eltrombopag Clinical Studies in Patients with Chronic Immune Thrombocytopenia

Nichola Cooper, MRCP, MRCPath, MD, Raymond Wong, Andres Brainsky, MD, Christine K Bailey, PhD

Blood (2011) 118 (21): 1164.

https://doi.org/10.1182/blood.V118.21.1164.1164

Published: 2011

Journal Articles

Lymphocyte Homeostasis FAS Pathway Is Altered in Some Patients with Immune Thrombocytopenia.

Nichola Cooper, MRCP, MRCPath, MD, V. Koneti Rao, MD, FRCPA, Thomas Fleisher, James B. Bussel, MD

Blood (2009) 114 (22): 3514.

https://doi.org/10.1182/blood.V114.22.3514.3514

Published: 2009

Journal Articles

Pre-Transplant PET Status May Not Impact on Survival Following Reduced-Intensity Allogeneic Stem-Cell Transplant for Lymphoma. However, Post-Transplant Surveillance with PET May Be Important for Directing Immunotherapy.

Jonathan R Lambert, MRCP, Jamshed B Bomanji, PhD, Nichola Cooper, MRCP, MRCPath, MD, Daniel P Hart, MRCP, Karl Peggs, Kirsty Thomson, Peter J Ell, FMedSci, Stephen Mackinnon, MD

Blood (2008) 112 (11): 3256.

https://doi.org/10.1182/blood.V112.11.3256.3256

Published: 2008

NARROW

Two-Year Safety and Efficacy Outcomes with Fostamatinib in Adult Patients with Immune Thrombocytopenia (ITP): Open-Label Extension to Phase 3 Trial Program

Autoimmune Cytopenias Following Alemtuzumab-Induced Renal Transplant: Clinical Features and Treatment Outcomes

Real World Use of Thrombopoietin-Receptor Agonists in the Management of Immune Thrombocytopenia in the United Kingdom: Results from the TRAIT Study

Active Immune Thrombocytopenia (ITP) Disease Is Characterised By a Reduced Treg:CD8 Effector T Cell Ratio Which Is Modulated By Thrombopoietin-Receptor Agonists (TPO-RA)

Safety and Efficacy of Romiplostim in over 200 Children with Immune Thrombocytopenia (ITP): Results of an Integrated Database of 5 Clinical Trials

Bayesian Analysis of TPO Levels in Immune Thrombocytopenia

Results from the ITP World IMPACT Survey (I-WISh): Patients with Immune Thrombocytopenia (ITP) Experience Impaired Quality of Life (QoL) Regarding Daily Activities, Social Interactions, Emotional Well-Being and Working Lives

Patients with Immune Thrombocytopenia (ITP) Frequently Experience Severe Fatigue but Is It Under-Recognized By Physicians: Results from the ITP World Impact Survey (I-WISh)

Rate of Cataracts Across the Eltrombopag Clinical Studies in Patients with Chronic Immune Thrombocytopenia

Lymphocyte Homeostasis FAS Pathway Is Altered in Some Patients with Immune Thrombocytopenia.

Pre-Transplant PET Status May Not Impact on Survival Following Reduced-Intensity Allogeneic Stem-Cell Transplant for Lymphoma. However, Post-Transplant Surveillance with PET May Be Important for Directing Immunotherapy.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only